Business Segments · Payments for Restructuring
Prescription Technology Solutions — Payments for Restructuring
McKesson Prescription Technology Solutions — Payments for Restructuring decreased by 100.0% to $0.00 in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $1.00M to $0.00. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryLiquidity
SignalLower is better
VolatilityVolatile
First reportedQ1 2020
Last reportedQ2 2025
How to read this metric
High cash payments indicate the active execution phase of restructuring, while lower payments suggest the program is nearing completion.
Detailed definition
Represents the actual cash outflows made to settle liabilities associated with restructuring activities in the Prescript...
Peer comparison
Often found in the 'Cash Flow from Operating Activities' section or segment-level cash flow disclosures of peer companies.
Metric ID:
mck_segment_prescription_technology_solutions_payments_for_restructuringHistorical Data
5 periods
| Q2 '21 | Q2 '22 | Q2 '23 | Q2 '24 | Q2 '25 | |
|---|---|---|---|---|---|
| Value | $1.00M | $2.00M | $13.00M | $1.00M | $0.00 |
| QoQ Change | — | +100.0% | +550.0% | -92.3% | -100.0% |
| YoY Change | — | +100.0% | +550.0% | -92.3% | -100.0% |
Range$0.00 – $13.00M
CAGR-100.0%
Avg YoY Growth+114.4%
Median YoY Growth+3.8%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's prescription technology solutions — payments for restructuring?
- McKesson (MCK) reported prescription technology solutions — payments for restructuring of $0.00 in Q2 2025.
- How has McKesson's prescription technology solutions — payments for restructuring changed year-over-year?
- McKesson's prescription technology solutions — payments for restructuring decreased by 100.0% year-over-year, from $1.00M to $0.00.
- What does prescription technology solutions — payments for restructuring mean?
- The actual cash spent on executing restructuring plans within the technology solutions segment.